The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Strategic planning to transform pancreatic cancer care: A comprehensive interdisciplinary roadmap.
 
Todd Aguilera
Leadership - ALPA Biosciences
Stock and Other Ownership Interests - AKSO Biopharmaceutical; ALPA Biosciences; Avelas Biosciences
Research Funding - Apexigen (Inst); Galera Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Patent from Stanford with royalties for licensing to Akso Biosciences; Patent from UCSD with royalties for licensing to Avelas Biosciences
 
Minda Hill
No Relationships to Disclose
 
Lan Vu
No Relationships to Disclose
 
Shelli Hardy
No Relationships to Disclose
 
Neha Barrows
No Relationships to Disclose
 
Lisa Ross
No Relationships to Disclose
 
Tammy Wynn
No Relationships to Disclose
 
Anne Stoecklin
No Relationships to Disclose
 
Natalie Ripley
No Relationships to Disclose
 
Remington Fenter
Stock and Other Ownership Interests - ABSCI Corporation; Candel Therapeutics; Cyclacel; CytomX Therapeutics; EnvoyAI; Ocular Therapeutix; Tilray; Vyne Therapeutics
 
Carrie Stricker
Stock and Other Ownership Interests - Carevive Systems; Health Catalyst
Honoraria - UpToDate
 
Rebekkah Schear
No Relationships to Disclose
 
Mujeeb Basit
No Relationships to Disclose
 
Jason Fleming
Stock and Other Ownership Interests - Bio-Path Holdings
Consulting or Advisory Role - Bio-Path Holdings; Candel Therapeutics; Covidien/Medtronic; GlycosBio; MyCareGorithm; PanTher Therapeutics
Patents, Royalties, Other Intellectual Property - U.S. Application No. 15/780,799, based on International Application No. PCT/US2016/065763, entitled “Polymeric Drug Delivery Systems For Treatment of Disease,” by Chun Li et al.; In the Name of Board of Regents, The University of Texas System
 
Kajal Desai
No Relationships to Disclose
 
Kyle Taylor
No Relationships to Disclose
 
Patricio Polanco
Consulting or Advisory Role - Intuitive Surgical; Iota Biomedical
 
Salwan Al Mutar
Employment - Cardinal Health
Honoraria - OMNI Health Media; Targeted Oncology
Consulting or Advisory Role - UrState
Research Funding - Arcus Biosciences (Inst); CG Pharmaceuticals (Inst); Courante Oncology (Inst); RenovoRx (Inst)
Travel, Accommodations, Expenses - Cardinal Health